Clinical trials of anti-avian influenza drugs in Thailand are effective

Thai medicine officials recently announced that,Thailand's self-developed anti-avian influenza drugs have passed the clinical trial stageThe results showed that, the drugto treat H5N1 highly pathogenic avian influenza virus infection,and has a high safety,is expected to be officially put into use in two months, the anti-bird flu drug "A
-
FLU" developed in Thailand using imported raw materials successfully passed 30 clinical trials, said Monkon Givadigan, director of the Thai government's drug organizationAt the same time, experts compared the treatment effect of the new drug and the Swiss anti-bird flu drug Tamiflu, the results are "satisfactory"At present, "A
-
FLU" has entered the Registration and Certification phase of the Thai Food Drug
administration Once licensed for production, the new drug could produce up to 400,000 tablets a day, Montion said When it goes into production, the new drug will cost nearly half as much as Tamiflu The new drug and the main ingredient of Tamiflu are reported to be oseltamivir Oseltamivir is an oral drug used to treat influenza, which breaks down and inhibits neuraminidase on the surface of influenza viruses in the body, reducing replication of influenza A and B viruses and reducing its ability to spread The Thai government's drug organization has made breakthroughs in the synthesis of oseltamivir and has developed new drugs (reproduced from China Medical Daily)